IL2 and neoplasm: A number of studies have been reported demonstrating the ability of interferon alpha and interleukin-2 (IL-2) to engender a tumour response (Fyfe et al, 1995; Pyrhonen et al, 1999; MRCRC Collaborators, 1999; Yang et al, 2003b; McDermott et al, 2005).